Long pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #1,701 to #1,750.
- (hist) PatientInfoPage [48,002 bytes]
- (hist) Carbohydrate response element gene transcriptions [47,989 bytes]
- (hist) Tables [47,989 bytes]
- (hist) Ritonavir [47,983 bytes]
- (hist) Propafenone [47,982 bytes]
- (hist) Lung cancer diagnostic study of choice [47,947 bytes]
- (hist) Tretinoin (topical) [47,944 bytes]
- (hist) Dapagliflozin [47,935 bytes]
- (hist) Uncertainty principle [47,904 bytes]
- (hist) ICD-10 Chapter XIX: Injury, poisoning and certain other consequences of external causes [47,904 bytes]
- (hist) Minamata disease [47,903 bytes]
- (hist) Copyright [47,886 bytes]
- (hist) Sandbox:septic arthritis [47,872 bytes]
- (hist) Sargramostim [47,870 bytes]
- (hist) Nicardipine [47,810 bytes]
- (hist) Metronidazole (oral) [47,796 bytes]
- (hist) Hypothyroidism [47,793 bytes]
- (hist) Sandbox simrat [47,790 bytes]
- (hist) Repaglinide [47,790 bytes]
- (hist) Darunavir ethanolate and cobicistat [47,783 bytes]
- (hist) Amoxicillin-Clavulanate [47,774 bytes]
- (hist) Helium [47,733 bytes]
- (hist) COPD exacerbation resident survival guide [47,728 bytes]
- (hist) Tramadol [47,712 bytes]
- (hist) Long-term potentiation [47,701 bytes]
- (hist) Ciclesonide (inhalation) [47,691 bytes]
- (hist) Sandbox TB [47,679 bytes]
- (hist) IncobotulinumtoxinA [47,674 bytes]
- (hist) The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS I Guidelines [47,668 bytes]
- (hist) Folic acid detailed information [47,664 bytes]
- (hist) Carbidopa [47,663 bytes]
- (hist) Nanotechnology [47,659 bytes]
- (hist) Global dimming [47,649 bytes]
- (hist) Benazepril hydrochloride/Hydrochlorothiazide [47,648 bytes]
- (hist) Sandbox ID Lower Respiratory Tract [47,640 bytes]
- (hist) Phosphate budgets [47,612 bytes]
- (hist) Species [47,611 bytes]
- (hist) Exenatide [47,600 bytes]
- (hist) Steatorrhea differential diagnosis [47,599 bytes]
- (hist) Coronary artery calcification [47,597 bytes]
- (hist) Human factors [47,587 bytes]
- (hist) Consciousness [47,577 bytes]
- (hist) Warfarin (oral) [47,577 bytes]
- (hist) Repaglinide and Metformin hydrochloride [47,574 bytes]
- (hist) Osteoporosis medical therapy [47,549 bytes]
- (hist) Traditional Chinese medicine [47,539 bytes]
- (hist) Maximum parsimony [47,530 bytes]
- (hist) Biodiversity [47,525 bytes]
- (hist) Familial hypercholesterolemia [47,484 bytes]
- (hist) Tamsulosin [47,463 bytes]